Iridia Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series B1
- (In Progress)
- Investors
-
15
Iridia General Information
Description
Developer of data storage technology designed to reduce the infrastructure requirements and associated environmental impact. The company combines proprietary enzymology and semiconductor technology to build an affordable and integrated data storage tool that can write, store, and read data in the form of format, enabling businesses to reduce the costs of storing dense and volumes of data.
Contact Information
Website
www.iridia.comCorporate Office
- 5937 Darwin Court
- Suite 109
- Carlsbad, CA 92008
- United States
Corporate Office
- 5937 Darwin Court
- Suite 109
- Carlsbad, CA 92008
- United States
Iridia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B1) | 05-Feb-2026 | In Progress | Generating Revenue | |||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Grant | 15-Apr-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 15-Nov-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A3) | 16-Mar-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | 15-Dec-2017 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 08-Feb-2017 | $940K | $1.34M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 24-Mar-2016 | $400K | $400K | Completed | Generating Revenue |
Iridia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 2,410,251 | $0.001000 | $0.39 | $0.39 | 1x | $0.39 | 6.69% | |
| Series A | 2,500,000 | $0.001000 | $0.16 | $0.16 | 1x | $0.16 | 6.94% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Iridia Comparisons
Industry
Financing
Details
Iridia Competitors (1)
One of Iridia’s competitors is Twist Bioscience, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Twist Bioscience | Formerly VC-backed | South San Francisco, CA |
Iridia Patents
Iridia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026198807-A1 | Time-resolved authentication using dna | Pending | 19-Mar-2025 | ||
| WO-2026193342-A1 | Multi-level counterfeit protection using dna | Pending | 12-Mar-2025 | ||
| WO-2026107468-A2 | Systems and methods for writing data stored in a polymer using light | Pending | 15-Nov-2024 | ||
| WO-2026107468-A3 | Systems and methods for writing data stored in a polymer using light | Pending | 15-Nov-2024 | ||
| AU-2024342565-A1 | Counterfeit protection using dna | Pending | 12-Sep-2023 | G06N3/123 |
Iridia Signals
Iridia Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Duke Capital Partners | Venture Capital | Minority | ||
| Minetta Brook Capital | Venture Capital | Minority | ||
| Prime Movers Lab | Venture Capital | Minority | ||
| ATEM Capital | Venture Capital | Minority |
Iridia FAQs
-
When was Iridia founded?
Iridia was founded in 2016.
-
Where is Iridia headquartered?
Iridia is headquartered in Carlsbad, CA.
-
What is the size of Iridia?
Iridia has 27 total employees.
-
What industry is Iridia in?
Iridia’s primary industry is Other Commercial Products.
-
Is Iridia a private or public company?
Iridia is a Private company.
-
What is Iridia’s current revenue?
The current revenue for Iridia is .
-
How much funding has Iridia raised over time?
Iridia has raised $31.8M.
-
Who are Iridia’s investors?
National Institutes of Health, Duke Capital Partners, Minetta Brook Capital, Prime Movers Lab, and ATEM Capital are 5 of 15 investors who have invested in Iridia.
-
Who are Iridia’s competitors?
Twist Bioscience is a competitor of Iridia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process